Norman Schwartz - Sep 1, 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO BIOB)

Role
Chairman, President, and CEO, Director, 10%+ Owner
Signature
/s/ Norman Schwartz
Stock symbol
BIO BIOB
Transactions as of
Sep 1, 2024
Transactions value $
-$1,736,498
Form type
4
Date filed
9/4/2024, 08:35 PM
Previous filing
Aug 28, 2024
Next filing
Sep 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +3.01K +0.69% $0.00 436K Sep 1, 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability -$542K -1.61K -0.37% $337.32 434K Sep 1, 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +2.08K +0.48% $0.00 436K Sep 1, 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability -$270K -801 -0.18% $337.32 436K Sep 1, 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +1.27K +0.29% $0.00 437K Sep 1, 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability -$184K -545 -0.12% $337.32 436K Sep 1, 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +1.81K +0.41% $0.00 438K Sep 2, 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability -$326K -965 -0.22% $337.32 437K Sep 2, 2024 Direct
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $0 +2.32K +0.53% $0.00 439K Sep 3, 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Tax liability -$415K -1.24K -0.28% $334.31 438K Sep 3, 2024 Direct
holding BIO BIOB Bio-Rad B Common Stock 13K Sep 1, 2024 By Spouse F2
holding BIO BIOB Bio-Rad B Common Stock 4.06M Sep 1, 2024 By Blue Raven Partners, L.P. F3
holding BIO BIOB Bio-Rad B Common Stock 361K Sep 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -3.01K -25% $0.00 9.02K Sep 1, 2024 Bio-Rad A Common Stock 3.01K $0.00 Direct F4, F5
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -2.08K -33.32% $0.00 4.16K Sep 1, 2024 Bio-Rad A Common Stock 2.08K $0.00 Direct F4, F6
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -1.27K -50% $0.00 1.27K Sep 1, 2024 Bio-Rad A Common Stock 1.27K $0.00 Direct F4, F7
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -1.81K -100% $0.00 0 Sep 2, 2024 Bio-Rad A Common Stock 1.81K $0.00 Direct F4, F8
transaction BIO BIOB Restricted Stock Units Options Exercise $0 -2.32K -100% $0.00 0 Sep 3, 2024 Bio-Rad A Common Stock 2.32K $0.00 Direct F4, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 The reporting person disclaims beneficial ownership of these shares.
F3 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5 On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F7 On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F8 On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F9 On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.